The gastrointestinal KATP-ERK signaling axis: Molecular mechanisms, pharmacological opportunities, and emerging translational technologies - 07/11/26
, Marina Antonacci a, Antonella Orlando c, Simona Drago c, Eleonora Malerba c, Francesco Russo c, Domenico Tricarico aAbstract |
Background |
ATP-sensitive potassium channels are metabolic sensors that couple intracellular nucleotide availability to membrane excitability, calcium signaling, mitochondrial function, and cell survival. Growing evidence identifies K ATP channels as essential regulators of gastrointestinal physiology. They are expressed in smooth muscle, enteric neurons, interstitial cells of Cajal, epithelial and enteroendocrine cells, microvascular cells, pericytes, and liver, where they contribute to motility, secretion, barrier integrity, nutrient sensing, vascular regulation, and mucosal protection. In parallel, ERK1/2 are central effectors of the MAPK pathway, controlling epithelial renewal, inflammation, fibrosis, apoptosis, and tissue repair. This review proposes an integrated K ATP -ERK signaling network that regulates gastrointestinal homeostasis.
Methods |
PubMed and Scopus were searched for relevant studies using combinations of the terms “ERK” AND “K ATP channels” AND “cardiovascular” OR “gastrointestinal”.
Results |
Evidence supports functional crosstalk between K ATP channels and ERK signaling. In this framework, K ATP channels act as metabolic rheostats, whereas ERK integrates redox, growth factor, and stress-related signals. Acute K ATP activation promotes adaptation by preserving mitochondrial function and epithelial barrier integrity, whereas chronic channel overactivation, as observed in Cantú syndrome caused by gain-of-function mutations in ABCC9 or KCNJ8 , may induce maladaptive remodeling, tight junction disruption, apoptosis, fibrosis, and dysmotility. The potential involvement of FGFR/Klotho signaling as an upstream ERK regulator, together with K ATP /ERK pharmacological modulation, FGF/Klotho-based therapies, and biosensor technologies for pathway monitoring in organoids and gut-on-chip models, is also discussed.
Conclusions |
The K ATP -ERK-FGFR/Klotho framework links ion-channel pharmacology with gastrointestinal biology, providing a foundation for biomarker discovery, therapeutic development, and precision medicine approaches in gastrointestinal disorders.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Keywords : K ATP channels , ERK1/2, FGF/Klotho, Gastrointestinal apparatus, Intestinal epithelial barrier, Pharmacology, Biosensor
Plan
Vol 204
Article 119986- novembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
